CNX acquires four cancer drugs from Clinigen
The purchased therapies concerned are Cardioxane, Totect, Ethyol and Savene
Read More
Tag: CNX
CNX embarks on buy-and-build strategy
Investment is a key boost to the acceleration of treatment access in the UK
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
